Journey Advisory Group’s iShares US Medical Devices ETF IHI Stock Holding History

Journey Advisory Group’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.62M	Buy	+134,066	New	+$6.81M	0.51%	52

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Journey Advisory Group's IHI Position: Q2 2026 in Review

Journey Advisory Group opened a new position in iShares US Medical Devices ETF (IHI) in Q2 2026: 134,066 shares worth $6.62M. The stake represents 0.51% of the portfolio and ranks #52 among its holdings.

500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Journey Advisory Group held 134,066 shares of iShares US Medical Devices ETF worth $6.62M as of Q2 2026.
iShares US Medical Devices ETF was a new Journey Advisory Group position in Q2 2026.
iShares US Medical Devices ETF made up 0.51% of Journey Advisory Group's portfolio in Q2 2026, its #52 holding.
500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Journey Advisory Group's 13F filing for Q2 2026, filed 4 Aug 2026.